ESR1 and breast cancer: A recent study by the same group identified at least two fusion genes (ERα-e6 > YAP1 and ERα–e6 > PCDH11X) in advanced ER+ BC and palbociclib was observed to inhibit the fusion gene driven T47D growth under hormone deprived conditions in a dose-dependent manner (257).